{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T09:29:52Z","timestamp":1768123792230,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jid.2018.10.041","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T10:43:11Z","timestamp":1543315391000},"page":"1127-1134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma"],"prefix":"10.1016","volume":"139","author":[{"given":"Laura K.","family":"Ferris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Sligh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuxu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clay J.","family":"Cockerell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.10.041_bib1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"65","author":"Bichakjian","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6225","key":"10.1016\/j.jid.2018.10.041_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1260200","article-title":"TERT promoter mutations and telomerase reactivation in urothelial cancer","volume":"347","author":"Borah","year":"2015","journal-title":"Science"},{"issue":"6358","key":"10.1016\/j.jid.2018.10.041_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aao0535","article-title":"Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism","volume":"357","author":"Chiba","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jid.2018.10.041_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamadermatol.2017.4773","article-title":"Noninvasive gene expression testing in amelanotic melanoma","volume":"154","author":"Childs","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2018.10.041_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2018.10.041_bib43","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2018.10.041_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/CMR.0000000000000478","article-title":"Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions","volume":"28","author":"Ferris","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2018.10.041_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamadermatol.2017.0473","article-title":"Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy","volume":"153","author":"Ferris","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2018.10.041_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2016.07.038","article-title":"Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma","volume":"76","author":"Gerami","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jid.2018.10.041_bib11","doi-asserted-by":"crossref","first-page":"dju246","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2018.10.041_bib12","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":"The gene expression signatures of melanoma progression","volume":"102","author":"Haqq","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.10.041_bib13","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.18632\/oncotarget.16698","article-title":"Genetic alterations in seborrheic keratoses","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2018.10.041_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2017.06.015","article-title":"Detection of genetic aberrations in the assessment and prognosis of melanoma","volume":"35","author":"High","year":"2017","journal-title":"Dermatol Clin"},{"issue":"6122","key":"10.1016\/j.jid.2018.10.041_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jid.2018.10.041_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2018.1764","article-title":"Economic analysis of a noninvasive molecular pathologic assay for pigmented skin lesions","volume":"154","author":"Hornberger","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"6122","key":"10.1016\/j.jid.2018.10.041_bib18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jid.2018.10.041_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/genes7070038","article-title":"Cancer-specific telomerase reverse transcriptase (TERT) promoter mutations: biological and clinical implications","volume":"7","author":"Liu","year":"2016","journal-title":"Genes"},{"key":"10.1016\/j.jid.2018.10.041_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamadermatol.2017.4060","article-title":"Population-based analysis of histologically confirmed melanocytic proliferations using natural language processing","volume":"154","author":"Lott","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jid.2018.10.041_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-015-1784-x","article-title":"Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness","volume":"467","author":"Macerola","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jid.2018.10.041_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/bjd.13121","article-title":"Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety","volume":"171","author":"Malvehy","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.10.041_bib24","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-13-0398","article-title":"BRAF\/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage","volume":"19","author":"Mar","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.10.041_bib25","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","article-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","volume":"18","author":"Menzies","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.10.041_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.30042","article-title":"TERT promoter mutations in melanoma survival","volume":"139","author":"Nagore","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2018.10.041_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jamadermatol.2017.6448","article-title":"Dermoscopy and overdiagnosis of melanoma in situ","volume":"154","author":"Nufer","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2018.10.041_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.cmr.0000222600.73179.f3","article-title":"BRAF and NRAS mutations in melanoma and melanocytic nevi","volume":"16","author":"Poynter","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2018.10.041_bib30","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A\u00a0comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2018.10.041_bib31","first-page":"1","article-title":"Non-invasive gene expression testing to rule out melanoma","volume":"23","author":"Rivers","year":"2018","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jid.2018.10.041_bib32","first-page":"134","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients","volume":"7","author":"Roh","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jid.2018.10.041_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2018.10.041_bib34","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6358","key":"10.1016\/j.jid.2018.10.041_bib35","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.aao6963","article-title":"New insights into melanoma development","volume":"357","author":"Shay","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jid.2018.10.041_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2018.10.041_bib38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2018.10.041_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/adt.2016.724","article-title":"Analytical characteristics of a noninvasive gene expression assay for pigmented skin lesions","volume":"14","author":"Yao","year":"2016","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.jid.2018.10.041_bib41","first-page":"611","article-title":"An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies","volume":"16","author":"Yao","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jid.2018.10.041_bib42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jnci\/djt119","article-title":"Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia","volume":"105","author":"Yeh","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1832894X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1832894X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T23:16:38Z","timestamp":1662506198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1832894X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0022202X1832894X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.10.041","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}